Late Effects of Hematopoietic Stem Cell Transplantation

References

• Armitage, J. O. (1994). Research potential of the ABMTR Database, Autologous Blood and Marrow Transplant Registry-North America, 1, 2.
   Google Scholar
• Sullivan, K. M., Agura, E., Anasetti, C., Appelbaum, F., Badger, C., Bearman, S., Erickson, K., Flowers, M., Hansen, J., Loughran, T., Martin, P., Matthews, D., Petersdorf, E., Radich, J., Riddell, S., Rovira, D., Sanders, J., Schuening, F., Siadak, M., Storb, R. and Witherspoon, R. (1991). Chronic graft-versus-host disease and other late complications of bone marrow transplantation, Semin Hematol, 28, 250–259.
   PubMed Web of Science ®Google Scholar
• Bearman, S. I., Appelbaum, F. R. and Buckner, C. D. et al. (1988). Regimen-related toxicity In patients undergoing bone marrow transplantation, J Clin Oncol, 6, 1562–1568.
   PubMed Web of Science ®Google Scholar
• Benyunes, M. C., Sullivan, K. M., Deeg, H. J., Mori, M., Meyer, W., Fisher, L., Bensinger, W., Jack, M. K., Hicks, J., Witherspoon, R., Buckner, C. D., Hansen, J. A., Appelbaum, F. R. and Storb, R. (1995). Cataracts after bone marrow transplantation: Long-term follow-up of adults treated with fractionated total body irradiation, Int J Radiat Oncol Biol Phys, 32, 661–70.
   PubMed Web of Science ®Google Scholar
• Thompson, C. B., Sanders, J. E., Flournoy, N., Buckner, C. D. and Thomas, E. D., (1986). The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia, Blood, 67, 195–199.
   PubMed Web of Science ®Google Scholar
• Sullivan, K. M., Mori, M., Sanders, J. E., Siadak, M., Witherspoon, R. P., Anasetti, C., Appelbaum, F. R., Bensinger, W., Bowden, R., Buckner, C. D., Clark, J., Crawford, S., Deeg, H. J. Doney, K., Flowers, M., Hansen, J., Loughran, T., Martin, P., McDonald, G., Pepe, M., Petersen, F. B., Schuening, F., Stewart, P. and Storb, R. (1992). Late complications of allogeneic and autologous marrow transplantation (Review), Bone Marrow Transplant, 10, 127–134.
   PubMed Web of Science ®Google Scholar
• Atkinson, K., Biggs, J. and Darveniza, P., et al. (1984). Cyclosporine-associated central nervous system toxicity after allogeneic bone marrow transplantation, Transplantation, 38, 34–37.
   PubMed Web of Science ®Google Scholar
• Sanders, J. E. (1999). Growth and development after bone marrow transplantation. In: Hematopoietic Stem Cell Transplantation, Forman S. J., Blume K. G., Thomas E. D. (eds), Boston, 2nd Edition, Blackwell Scientific Publishers, 527–537.
   Google Scholar
• Wingard, J. R., Plotnick, L. P., Freemer, C. S., Zahurak, M., Piantadosi, S., Miller, D. F., Huibert, M., Vriesendorp, H. M., Yeager, A. M. and Santos, G. W. (1992). Growth in children after bone marrow transplantation: Busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation, Blood, 79, 1068–1073.
   PubMed Web of Science ®Google Scholar
• Heimpel, H., Arnold, R., Hetzel, W. D., Hueske, D., Kreuser, E. D., Wirthenson, E. F., Voss, A. C. and Slanina, J. (1991). Gonadal function after bone marrow transplantation in adult male and female patients, Bone Marrow Transplant, 8 (Suppl. 1), 21–24.
   PubMedGoogle Scholar
• Sanders, J. E., Buckner, C. D., Leonard, J. M., Sullivan, K. M., Witherspoon, R. P., Deeg, H. J., Storb, R. and Thomas, E. D. (1983). Late effects on gonadal function of cyclophosphamide, total-body, and marrow transplantation, Transplantation, 36, 252–255.
   PubMed Web of Science ®Google Scholar
• Tanner, J. M. and Whitehouse, R. H. (1976). Clinical longitudinal standards for height, weight, weight velocity, and stages of puberty, Arch Dis Child, 51, 170–9.
   PubMed Web of Science ®Google Scholar
• Schubert, M. A., Sullivan, K. M., Schubert, M. M., Nims, J. E., Hansen, J. M., Sanders, J. E., O'Quigley, J., Witherspoon, R. P., Buckner, C. D., Storb, R. and Thomas, E. D. (1990). Gynecological abnormalities following allogeneic bone marrow transplantation, Bone Marrow Transplant, 5, 425–430.
   PubMed Web of Science ®Google Scholar
• Hinterberger-Fischer, M., Kier, P., Kalhs, P., Marosi, C., Geissler, K., Schwarzinger, I., Pabinger, I., Huber, J., Spona, J., Kolbabek, H., Koren, H., Muller, G., Hawliczek, R., Lechner, K., Hayek-Rosenmayr, A. and Hinterberger, W. (1991). Fertility, pregnancies and offspring complications after bone marrow transplantation, Bone Marrow Transplant, 7, 5–9.
   PubMed Web of Science ®Google Scholar
• Sanders, J. E., Hawley, J., Levy, W., Gooley, T., Buckner, C. D., Deeg, H. J., Doney, K., Storb, R., Sullivan, K. M., Witherspoon, R. and Appelbaum, F. R. (1996). Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total body irradiation and bone marrow transplantation, Blood, 87, 3045–3052.
   PubMed Web of Science ®Google Scholar
• Witherspoon, R. P., Lum, L. G. and Storb, R. (1984). Immunologic reconstitution after human marrow grafting, Semin Hematol, 21, 2–10.
   PubMed Web of Science ®Google Scholar
• Atkinson, K., Farewell, V., Storb, R., Tsoi, Mang-So., Sullivan, K. M., Witherspoon, R. P., Fefer, A., Clift, R., Goodell, B., and Thomas, E. D. (1982). Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of non-specific suppressor cells in patients with chronic graft-versus-host disease, Blood, 6, 714–720.
   Google Scholar
• Olsen, G. A., Gockerman, J. P., Bast, R. C., Borowitz, M. Jr. and Peters, W. P. (1988). Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone-marrow support, Transplantation, 46, 57–60.
   PubMed Web of Science ®Google Scholar
• Aucouturier, P., Barra, A., Intrator, L., Cordonnier, C., Schulz, D., Duarte, F., Vernant, J-P., Oreud'homme, J-L. (1987). Long lasting IgG subclass and anti-bacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation, Blood, 70, 779–785.
   PubMed Web of Science ®Google Scholar
• Sullivan, K. M., Siadak, M. F. and Witherspoon, R. W. (1990). Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation, Transplant Proc, 22, 1336–38.
   PubMed Web of Science ®Google Scholar
• Atkinson, K., Storb, R., Prentice, R. L., Witherspoon, Weiden, R. P., Sullivan, K. M., Noel, D. and Thomas, E. D. (1979). Analysis of late infections in 89 long-term survivors of bone marrow transplantation, Blood, 53, 720–731.
   PubMed Web of Science ®Google Scholar
• Winston, D. J., Schiffman, G., Wang, D. C., Feig, S. A., Lin, C-H., Marso, E. L., Ho, W. G., Young, L. S. and Gale, R. P. (1979). Pneumococcal infections after human bone marrow transplantation, Ann Intern Med, 91, 835–841.
   PubMed Web of Science ®Google Scholar
• Jo-Anne, Van Burik, H. and Weisdorf, D. J. (1999). Infections in recipients of blood and marrow transplantation, Hematol Oncol. Clin. N. Am., 13, 1091–1112.
   PubMed Web of Science ®Google Scholar
• Winston, D. J., Schiffman, G., Wang, D. C., Feig, S. A., Lin, C-H., Marso, E. L., Ho, W. G., Young, L. S. and Gale, R. P. (1979). Pneumococcal infections after human bone marrow transplantation, Ann Intern Med, 91, 835–841.
   PubMed Web of Science ®Google Scholar
• Locksley, R. M., Flournoy, N., Sullivan, K. M. and Meyers, J. D. (1985). Infection with varicella-zoster virus after marrow transplantation, J Infect Dis, 152, 1172–1181.
   PubMed Web of Science ®Google Scholar
• Schuchter, L. M., Wingard, J. R., Piantadosi, S., Burns, W. H., Santos, G. W. and Saral, R. (1989). Herpes Zoster infection after autologous bone marrow transplantation, Blood, 74, 1424–1427.
   PubMed Web of Science ®Google Scholar
• Storek, J., Gooley, T., Siadak, M., Bensinger, W. I., Maloney, D. G., TR, Chauncey, flowers, M., Sullivan, K. M., Witherspoon, R. P., Rowley, S. D., Hansen, J. A., Storb, R. and Appelbaum, F. R. (1997). Allogeneic peripheral blood stem cell transplantation may be associated with a high-risk of chronic graft-versus-host disease, Blood, 90, 4705–4709.
   PubMed Web of Science ®Google Scholar
• Wingard, J. R., Piantadosi, S., Vogelsang, G. B., Farmer, E. R., Jabs, D. A., Levin, L. S., Beschomer, W. E., Cahill, R. A., Miller, D. F., Harrison, D., Saral, R. and Santos, G. W. (1989). Predictors of death from chronic graft-versus-host disease after bone marrow transplantation, Blood, 74, 1428–1435.
   PubMed Web of Science ®Google Scholar
• Sullivan, K. M. (1999). Graft-versus-host disease. In, Hematopoietic Stem Cell Transplantation 2nd edn., (eds.) Forman, S. J., Blume, K. G. and Thomas, E. D., pp. 515–536, Boston, Blackwell Scientific Publishers.
   Google Scholar
• Atkinson, K. (1990). Chronic graft-versus-host disease (review), Bone Marrow Transplant, 5, 69–82.
   PubMed Web of Science ®Google Scholar
• Shulman, H. M. (1978). Chronic cutaneous graft-versus-host disease in man, Am J Pathol, 91, 545–570.
   PubMed Web of Science ®Google Scholar
• Schubert, M. M., Sullivan, K. M. (1990). Recognition, incidence and management of oral graft-versus host disease, NCI Monographs, 9, 135–143.
   PubMedGoogle Scholar
• Clark, J. G., Schwartz, D. A., Flournoy, N., Sullivan, K. M., Crawford, S. W. and Thomas, E. D. (1989). Risk factors for airflow obstruction in recipients of bone marrow transplants, Ann Intern Med, 107, 648–656.
   Web of Science ®Google Scholar
• Clark, J. G., Crawford, S. W., Madtes, D. K. and Sullivan, K. M. (1989). Obstructive lung disease after allogeneic marrow transplantation, Ann Intern Med, 111, 368–376.
   PubMed Web of Science ®Google Scholar
• Fried, R. H., Murakami, C. S., Fisher, L. D., Wilson, R. A., Sullivan, K. M. and McDonald, G. B. (1992). Ursodeoxycholic acid treatment of refractory chronic graft-versus-host of the liver, Ann Intern Med., 116, 624–29.
   PubMed Web of Science ®Google Scholar
• Janin, A., Socie, G., Devergie, A., Aractingi, S., Esperou, H., Verola, O. and Gluckman, E. (1994). Fasciitis in chronic graft-versus-host disease, Ann Intern Med, 120, 993–998.
   PubMed Web of Science ®Google Scholar
• McDonald, G. B., Sullivan, K. M., Schuffler, M. D., Shulman, H. M. and Thomas, E. D. (1981). Esophageal abnormalities in chronic graft-versus-host disease in humans, Gastroenterology, 80, 914–921.
   PubMed Web of Science ®Google Scholar
• McDonald, G. B., Shulman, H. M., Sullivan, K. M. and Spencer, G. D. (1986). Intestinal and hepatic complications of human bone marrow transplantation, Gastroenterology, 90, 460–477; 770–784.
   PubMed Web of Science ®Google Scholar
• Sullivan, K. M., Meyers, J. D., Flournoy, N., Storb, R. and Thomas, E. D. (1986). Early and late interstitial pnemonia following human bone marrow transplantation, Int J Cell Cloning, 4, 107–121.
   PubMedGoogle Scholar
• Morton, A. J., Anasetti, C., Gooley, T., Flowers, M. E.D., Deeg, H. J., Hansen, J. A., Martin, P. J. and Sullivan, K. M. (1997a). Chronic graft-versus-host disease (GVHD) following unrelated donor transplantation, Blood, 90, 590a.
   PubMedGoogle Scholar
• Morton, A. J., Gooley, T., Hansen, J. A., Appelbaum, F. R., Bjerke, J. W., Clift, R., Martin, P. J., Petersdorf, E. W., Sanders, J. E., Storb, R. and Sullivan, K. M. (1997b). Impact of pre-transplant Interferon-alpha on outcome of unrelated donor marrow transplants for chronic myeloid leukemia (CML) in first chronic phase, Blood, 90, 105a.
   PubMed Web of Science ®Google Scholar
• Sullivan, K. M., Witherspoon, R. P., Storb, R., Weiden, P., Flournoy, N., Dahlberg, S., Deeg, J. H., Sanders, J. E., Doney, K. C., Appelbaum, F. R., McGuffin, R., McDonald, G. B., Meyers, J., Schubert, M. M., Gauvreau, J., Shulman, H. M., Sale, G. E., Anasetti, C., Loughran, T. P., Strom, S., Nims, J. and Thomas, E. D. (1988). Prednisone and azathioprine compared with prednisone and placebo for the treatment of chronic graft-versus-host disease: Prognostic prolonged thrombocytopenia after allogeneic marrow transplantation, Blood, 72, 545–558.
   Web of Science ®Google Scholar
• Vogelsang, G. B., Farmer, E. R., Hess, A. D., Altamonte, V., Beschomer, W. E., Jabs, D. A., Corio, R. L., Levin, L. S., Colvin, O. M., Wingard, J. R. and Santos, G. W. (1992). Thalidomide for the treatment of chronic graft-versus-host disease, N Engl J Med, 326, 1055–1058.
   PubMed Web of Science ®Google Scholar
• Nash, R. A., Furlong, T., Storb, R., Anasetti, C., Appelbaum, F. R., Deeg, H. J., Doney, K., Martin, R., Witherspoon, R. and Sullivan, K. M. (1997). Mycophenolate mofetil (MMF) as salvage treatment for graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT): Safety analysis, Blood, 90 (Suppl. 1), 459a (Abstract).
   Google Scholar
• Sullivan, K. M., Storek, J., Kopecky, K. J., Jocom, J., Longton, G., Howers, M., Siadak, M., Nims, J., Witherspoon, R. P., Anasetti, C., Appelbaum, F., Bowden, R. A., Buckner, D., Crawford, S. W., Deeg, H. J., Hansen, J. A., McDonald, G. B., Sanders, J. E. and Storb, R. (1996). A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-versus-host disease after marrow transplantation: Clinical outcome and effect on subsequent immune recovery, Biol Blood Bone Marrow Transplant, 2, 44–53.
   PubMedGoogle Scholar
• Kelly, P. J., Atkinson, K., Ward, R. L., Sambrook, P. N., Biggs, J. C. and Eisman, J. C. (1990). Reduced bone mineral density in men and women with allogeneic bone marrow transplantation, Transplantation, 50, 881–883.
   PubMed Web of Science ®Google Scholar
• Socie, G., Selimi, F., Sedel, L., Frija, J., Devergie, A., Esperou-Bourdeau, H., Ribaud, P. and Gluckman, E. (1994). Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors, Br J Haematol, 86, 624–628.
   PubMed Web of Science ®Google Scholar
• Stem, J. M., Chesnut, C. H., Bruemmer, B., Sullivan, K. M., Lenssen, P. S., Aker, S. N. and Sanders, J. (1996). Bone density loss during treatment of chronic GVHD, Bone Marrow Transplant, 17, 395–400.
   PubMed Web of Science ®Google Scholar
• Witherspoon, R. P., Fisher, L. D., Schoch, G., Martin, P., Sullivan, K. M., Sanders, J., Deeg, H. J., Doney, K., Thomas, D., Storb, R. and Thomas, E. D. (1989). Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia, N Engl J Med, 321, 784–789.
   PubMed Web of Science ®Google Scholar
• Witherspoon, R. P., Storb, R., Pepe, M., Longton, G. and Sullivan, K. M. (1992). Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone, Blood, 79, 289–292.
   PubMed Web of Science ®Google Scholar
• Socie, G., Henry-Amar, M., Bacigalupo, A., Hows, J., Tichelli, A., Ljungman, P., McCann, S. R., Frickhofen, N., Veer-Kirthof, E. V. and Gluckman, E. (1993). Malignant tumors occurring after treatment of aplastic anemia, N Engl J Med, 329, 1152–1157.
   PubMed Web of Science ®Google Scholar
• Deeg, H. J., Socie, G., Schoch, G., Henry-Amar, M., Witherspoon, R. P., Devergie, A., Sullivan, K. M., Gluckman, E. and Storb, R. (1996). Malignancies after marrow transplantation for aplastic anemia and Fanconi Anemia: A joint Seattle and Paris analysis of results in 700 patients, Blood, 87, 386–392.
   PubMed Web of Science ®Google Scholar
• Curtis, R. E., Rowlings, P. A., Deeg, H. J., Shriner, D. A., Socie, G., Travis, L. B., Horowitz, M. M., Witherspoon, R. P., Hoover, R. N., Sobocinski, K. A., Fraumeni, J. F. and Boice, J. D. (1997). Solid cancers after bone marrow transplantation, N Engl J Med, 336, 897–904.
   PubMed Web of Science ®Google Scholar
• Mortimer, J., Blinder, M. A., Schulman, S., Appelbaum, F. R., Buckner, C. D., Clift, R. A., Sanders, J. E., Storb, R. and Thomas, E. D. (1989). Relapse of acute leukema after marrow transplantation: natural history and results of subsequent therapy, J Clin Oncol, 7, 50–57.
   PubMed Web of Science ®Google Scholar
• Radich, J. P., Sanders, J. E., Buckner, C. D., Martin, P. J., Peterson, F. B., Bensinger, W., McDonald, G. B., Moro, M., Schoch, G. and Hansen, J. A. (1993). Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens, J Clin. Oncol, 11, 304–313.
   PubMed Web of Science ®Google Scholar
• Higano, C. S., Raskind, W. H. and Singer, J. W. (1992). Use of alpha-interferon for treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow Transplantation, Blood, 80, 1437–1442.
   PubMed Web of Science ®Google Scholar
• Weiden, P. L., Sullivan, K. M., Flournoy, N., Storb, R. and Thomas, E. D. and the Seattle Marrow Transplant Team. (1981). Anti-Leukemic Effect of Chronic Graft-versus-Host disease, N Engl J Med, 304, 1529–1533.
   PubMed Web of Science ®Google Scholar
• Sullivan, K. M., Storb, R., Buckner, C. D., Fefer, A., Fisher, L., Weiden, P. L., Witherspoon, R. P., Appelbaum, F. R., Banaji, M., Hansen, J., Martin, P., Sanders, J. E., Singer, J. and Thomas, E. D. (1989). Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms, N Engl J Med, 320, 828–834.
   PubMed Web of Science ®Google Scholar
• Kolb, H. J., Mittermuller, Ch. Clemm, J., Holler, E., Ledderose, G., Brehm, G., Heim, M. and Wilmanns, W. (1990). Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients, Blood, 76, 2462–2465.
   PubMed Web of Science ®Google Scholar
• Papadopoulos, E. B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M. H., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Small, T. N., Young, J. W., Kernan, N. A. and O'Reilly, R. J. (1994). Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation, N Engl J Med, 330, 1185–1191.
   PubMed Web of Science ®Google Scholar
• Wingard, J. R., Curbow, B., Baker, R. and Piantadosi, S. (1991). Health, functional status and employment of adult survivors of bone marrow transplantation, Ann Intern Med, 114, 113–118.
   PubMed Web of Science ®Google Scholar
• Chao, N. J., Tierney, D. K., Bloom, J. R., Long, G. D., Barr, T. A., Stallbaum, B. A., Wong, R. M., Negrin, R. S., Homing, S. J. and Blume, K. G. (1992). Dynamic assessment of quality of life after autologous bone marrow transplantation, Blood, 80, 825–830.
   PubMed Web of Science ®Google Scholar
• Schmidt, G. M., Niland, J. C., Forman, S. J., Fonbuena, P. P., Dagis, A. C., Grant, M. M., Ferrell, B. R., Barr, T. A., Stallbaum, B. A., Chao, N. J. and Blume, K. G. (1993). Extended follow-up of 212 long-term allogeneic bone marrow transplant survivors, Transplantation, 55, 551–557.
   PubMed Web of Science ®Google Scholar
• Syrjala, K. L., Chapko, M. K., Vitaliano, P. P., Cummings, C. and Sullivan, K. M. (1993). Recovery after allogeneic marrow transplantation: Prospective study of predictors of long-term physical and psychosocial functioning, Bone Marrow Transplantation, 11, 319–327.
   PubMed Web of Science ®Google Scholar
• Bush, N. E., Haberman, M., Donaldson, G. and Sullivan, K. M. (1995). Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation, Soc Sci Med, 40, 479–490.
   PubMed Web of Science ®Google Scholar